0001209191-22-021391.txt : 20220328 0001209191-22-021391.hdr.sgml : 20220328 20220328202411 ACCESSION NUMBER: 0001209191-22-021391 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220324 FILED AS OF DATE: 20220328 DATE AS OF CHANGE: 20220328 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wernli Miri Halperin CENTRAL INDEX KEY: 0001897615 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40360 FILM NUMBER: 22777111 MAIL ADDRESS: STREET 1: C/O MIND MEDICINE INC. STREET 2: ONE WORLD TRADE CENTER, SUITE 8500 CITY: NEW YORK STATE: NY ZIP: 10007 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Mind Medicine (MindMed) Inc. CENTRAL INDEX KEY: 0001813814 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1166 ALBERNI STEET STREET 2: SUITE 1604 CITY: VANCOUVER STATE: A1 ZIP: V6E 3Z3 BUSINESS PHONE: (212) 220-6633 MAIL ADDRESS: STREET 1: 1166 ALBERNI STEET STREET 2: SUITE 1604 CITY: VANCOUVER STATE: A1 ZIP: V6E 3Z3 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-03-24 0 0001813814 Mind Medicine (MindMed) Inc. MNMD 0001897615 Wernli Miri Halperin C/O MIND MEDICINE (MINDMED), INC. ONE WORLD TRADE CENTER, SUITE 8500 NEW YORK NY 10007 1 1 0 0 Executive President Subordinate Voting Shares 2022-03-24 4 A 0 600000 0.00 A 1275000 D Stock Option (Right to Buy) 1.18 2022-03-24 4 A 0 780000 0.00 A 2022-03-23 Subordinate Voting Shares 780000 4462500 D These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one subordinate voting share of the Issuer. The RSUs vest in 48 equal monthly installments beginning on April 24, 2022, subject, to the Reporting Person providing continuous service to the Issuer on each such vesting date. The option grant has an exercise price of $1.48 Canadian Dollars. This represents the exercise price in United States Dollars. The shares subject to the option vest and become exercisable with 1/48th of the total shares vesting monthly over 48 months from the vesting commencement date, March 24, 2022, subject to the Reporting Person providing continuous service to the Issuer as of each such vesting date. s/ Robert Barrow, Attorney-in-Fact 2022-03-28